Mannkind is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Recent Communications

2007 Annual Report.

In 2007, we made substantial progress toward our goal of bringing Technosphere Insulin to diabetes patients.more



MannKind Corporation Response to Recent Market Events.

Mannkind is absolutely committed to the continued development of its lead development product, Technosphere Insulin.
more

MannKind Addresses Pfizer's Announcement Regarding Exubera

Our Technosphere Insulin clinical program is designed to provide data on safety and efficacy in a broad group of patients with diabetes.

more

Copyright ©2007 MannKind Corporation. All rights reserved. glossary terms of use privacy site map